| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/02/2007 | US7156049 Release mechanism to interact with biota, in particular fauna that may outgrow available habitat |
| 01/02/2007 | CA2436275C Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/02/2007 | CA2417800C Novel microemulsion and micelle systems for solubilizing drugs |
| 01/02/2007 | CA2400578C Controlled-release compositions containing opioid agonist and antagonist |
| 01/02/2007 | CA2371550C Ziprasidone suspension |
| 01/02/2007 | CA2368615C Thiadiazolyl urea or thiourea derivatives for antiviral treatment |
| 01/02/2007 | CA2365495C Viral treatment |
| 01/02/2007 | CA2352361C Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide and the process for their preparation |
| 01/02/2007 | CA2339991C Microemulsions as solid dosage forms for oral administration |
| 01/02/2007 | CA2338780C Preparation capable of releasing medicinal substance at targeted site in intestine |
| 01/02/2007 | CA2336149C A membrane or matrix for controlling the permeation rate of drugs |
| 01/02/2007 | CA2328320C Encapsulated long chain alcohols |
| 01/02/2007 | CA2299511C A pharmaceutical composition having two coating layers |
| 01/02/2007 | CA2290538C Composition comprising finely divided, crystalline particles of budesonide |
| 01/02/2007 | CA2283408C Swallow tablet comprising paracetamol |
| 01/02/2007 | CA2278651C Effervescent microspheres and method for making them |
| 01/02/2007 | CA2236691C Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 01/02/2007 | CA2225628C Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 01/02/2007 | CA2211839C Use of melatonin for treating patients suffering from drug addiction |
| 12/30/2006 | CA2551327A1 Barrier for food particles |
| 12/29/2006 | CA2511158A1 Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
| 12/28/2006 | WO2006138735A2 Gel compositions for topical administration |
| 12/28/2006 | WO2006138723A2 Tissue coverings bearing cutomized tissue images |
| 12/28/2006 | WO2006138686A1 Estrogen compositions for vaginal administration |
| 12/28/2006 | WO2006138658A2 Permeant delivery system and methods for use thereof |
| 12/28/2006 | WO2006138641A2 Manufacturing process for tigecycline |
| 12/28/2006 | WO2006138571A2 Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance |
| 12/28/2006 | WO2006138431A2 Methods and pharmaceutical formulations for increasing bioavailability |
| 12/28/2006 | WO2006138330A2 Tissue treatment methods |
| 12/28/2006 | WO2006138278A1 Emetic embedded capsule |
| 12/28/2006 | WO2006138253A1 Pharmaceutical compositions of hops resins |
| 12/28/2006 | WO2006138227A1 Modified and immediate release memantine bead formulation |
| 12/28/2006 | WO2006138202A2 Pharmaceutical formulations for minimizing drug-drug interactions |
| 12/28/2006 | WO2006138186A1 Two-component pharmaceutical composition for the treatment of pain |
| 12/28/2006 | WO2006138145A1 Nucleic acid functionalized nanoparticles for therapeutic applications |
| 12/28/2006 | WO2006138098A1 Reinforced collagen scaffold |
| 12/28/2006 | WO2006138035A1 Vehicle for the delivery of topical lipid soluble pharmaceutical agents |
| 12/28/2006 | WO2006138026A2 Stable pharmaceutical compositions including motilin-like peptides |
| 12/28/2006 | WO2006137855A2 Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility |
| 12/28/2006 | WO2006137466A1 Pharmaceutical composition |
| 12/28/2006 | WO2006137443A1 Tablet containing hardly soluble active ingredient |
| 12/28/2006 | WO2006137433A1 Aqueous preparation having levocabastine solubilized therein |
| 12/28/2006 | WO2006137426A1 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 12/28/2006 | WO2006137289A1 Oil-containing solid and process for producing the same |
| 12/28/2006 | WO2006136927A1 Extended release formulations comprising venlafaxine |
| 12/28/2006 | WO2006136916A2 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same |
| 12/28/2006 | WO2006136302A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 12/28/2006 | WO2006136232A1 Bicalutamide adsorbates, process for preparing same, and pharmaceutical compositions thereof |
| 12/28/2006 | WO2006136198A1 Gellan seamless breakable capsule and process for manufacturing thereof |
| 12/28/2006 | WO2006136196A1 Gellan seamless breakable capsule and process for manufacturing thereof |
| 12/28/2006 | WO2006125132A3 Aerosolized fluoroquinolones and uses thereof |
| 12/28/2006 | WO2006110753A3 Deodorant body wash with lotion |
| 12/28/2006 | WO2006110555A3 Cleansing foaming sunscreen lotion |
| 12/28/2006 | WO2006106344A3 Abuse resistant capsules |
| 12/28/2006 | WO2006105367A3 Magnetically-labeled microparticles for oral drug delivery |
| 12/28/2006 | WO2006101462A3 Pharmaceutical preparation comprising perindopril erbumine and method of preparation and stabilisation thereof |
| 12/28/2006 | WO2006094640A3 Roflumilast and integrin inhibitor combination and method of treatment |
| 12/28/2006 | WO2006089973A3 Dosage form containing oxycodone and naloxone |
| 12/28/2006 | WO2006088487A3 Permanently linked, magnetic chains |
| 12/28/2006 | WO2006086865A3 Combi-preparation of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infections |
| 12/28/2006 | WO2006084211A3 Thermoplastic articles containing a medicament |
| 12/28/2006 | WO2006081347A3 Controlled release compositions comprising an antipsychotic agent |
| 12/28/2006 | WO2006077429A8 Anthelmintic composition |
| 12/28/2006 | WO2006076620A3 Bendamustine pharmaceutical compositions for lyophilisation |
| 12/28/2006 | WO2006072329A3 Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion |
| 12/28/2006 | WO2006067577A3 Stable non-dihydrate azithromycin oral suspensions |
| 12/28/2006 | WO2006065455A3 Chewable oral compositions containing an anti-microbial agent and methods of formulating the compositions to have acceptable germ kill properties and taste |
| 12/28/2006 | WO2006062826B1 Anti-viral uses of metal nanomaterial compositions |
| 12/28/2006 | WO2006061700A3 Rapid disintegrating taste masked compositions and a process for its preparations |
| 12/28/2006 | WO2006041409A8 Medical solution, method for producing and use thereof |
| 12/28/2006 | WO2006039129A8 Methods for making and using composites, polymer scaffolds, and composite scaffolds |
| 12/28/2006 | WO2006031191A8 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 12/28/2006 | WO2005030142A8 Rifalazil formulations |
| 12/28/2006 | WO2005025536A8 Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
| 12/28/2006 | US20060293389 Process for producing injectable gabapentin compositions |
| 12/28/2006 | US20060293327 Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof |
| 12/28/2006 | US20060293258 Method and composition to treat skin ulcers |
| 12/28/2006 | US20060293216 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion |
| 12/28/2006 | US20060292644 Novel tumor-associated marker |
| 12/28/2006 | US20060292244 Use of pvp-iodine liposomes for treatment of acne |
| 12/28/2006 | US20060292225 Water soluble analgesic formulations and methods for production |
| 12/28/2006 | US20060292224 Pharmaceutical composition |
| 12/28/2006 | US20060292223 Gel compositions for topical administration |
| 12/28/2006 | US20060292222 Drug delivery device having zero or near zero-order release kinetics |
| 12/28/2006 | US20060292221 Multilayer tablet; core containing drug with erodible filler and overcoating |
| 12/28/2006 | US20060292220 Compositions and methods for nutrition supplementation |
| 12/28/2006 | US20060292219 Making a tablet by combining a drug such as fentanyl with an effervescent agent used as penetration enhancer to influence the permeability of the medicament in the oral cavity; compressing to form tablet |
| 12/28/2006 | US20060292218 A cytocidyl mixture of alpha-ketoglutaric acid and salts, N-acetyl-seleno-L-methionine, N-acetyl-L-methionine, and 5-hydroxymethylfurfural that is capable of forming azomethine; angiogenesis inhibition; cancerous tumors of the breast, uterus, esophagus, bladder, lung |
| 12/28/2006 | US20060292217 Nutritional supplement and soft gelatin capsule delivery system |
| 12/28/2006 | US20060292216 Enteric delivery of (-)-hydroxycitric acid |
| 12/28/2006 | US20060292215 Abscisic acid against cancer |
| 12/28/2006 | US20060292214 Nanoparticulate acetaminophen formulations |
| 12/28/2006 | US20060292213 Enoximone formulations and their use in the treatment of PDE-III mediated diseases |
| 12/28/2006 | US20060292212 Use of thickening agents for producing soft capsules and film production method |
| 12/28/2006 | US20060292211 Ultrasound Enhancement of Drug Release Across Non-Ionic Surfactant Membranes |
| 12/28/2006 | US20060292210 Percutaneous absorption-type pharmaceutical preparation |
| 12/28/2006 | US20060292206 Devices and methods for treatment of vascular aneurysms |
| 12/28/2006 | US20060292199 PMMA bone cement containing antibiotic/antibiotics |
| 12/28/2006 | US20060292195 Tooth drops |
| 12/28/2006 | US20060292194 Treatment for burns and adipose deposits using thyroid hormone compound in a human |